Download PDF
Nervenheilkunde 2011; 30(07): 470-475
DOI: 10.1055/s-0038-1628381
Multiple Sklerose
Schattauer GmbH

Fatigue bei Multipler Sklerose

Mögliche Ursachen und Zusammenhänge, sinnvolle Diagnostik und TherapieFatigue in multiple sclerosispotential causes, and pathophysiology, implications for diagnosis and therapy
C. Veauthier
1   Klinik für Neurologie, Geriatrie und Palliativmedizin, Hanse-Klinikum Stralsund
› Author Affiliations
Further Information

Publication History

Eingegangen am: 10 January 2011

angenommen am: 02 March 2011

Publication Date:
23 January 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Fatigue ist das häufigste Symptom bei Patienten mit Multipler Sklerose (MS). Die Ursachen der Fatigue sind unklar. Diskutiert wurden neuroendokrine Ursachen, ein Zusammenhang mit der Läsionslast und Hirnatrophie, Depressionen, Nebenwirkungen von Medikamenten, Schlafstörungen und andere Ursachen. Eine Medikation mit Amantadin und Modafinil wurde mit wechselndem Erfolg eingesetzt, wobei deren Wirksamkeit durch Studien nicht belegt wurde. An nicht medikamentösen Therapien sind verhaltenstherapeutische und physiotherapeutische Maßnahmen wirksam. Es existieren keine diagnostischen objektiven Kriterien, die eine sichere Unterscheidung zwischen der Fatigue und einer durch Schlafstörungen bedingten Müdigkeit ermöglichen. Zunächst sollte jeder Fatigue-Patient gezielt zu Schlafstörungen befragt werden. Anamnestisch zu eruierende Schlafstörungen (z. B. Insomnie, Restless-legs-Syndrom, Schmerzen, Nykturie) sollten behandelt werden. Bei ausbleibender Besserung der Fatigue ist eine Polysomnografie zum Ausschluss einer schlafbezogenen Atemstörung und periodischer Beinbewegungen im Schlaf zu empfehlen.

Summary

Fatigue is the most common symptom in MS. The mechanism of fatigue is not known. A neuroendocrine origin as well as an increased lesion load and atrophy of gray and white matter and a relationship with depression and side-effects of the medication have been described. No specific successful drug-therapy exists, but amantadine and modafinil could be a therapeutic option and behavior therapy and physical therapy as well. We don`t yet have objective measurements to discriminate fatigue from tiredness. At first an accurate medical history should be taken and insomnia and restless legs syndrome, nycturia and pain should be treated consequently. In case of therapy resistance a polysomnography is needed.

Schlüsselwörter

Fatigue - Multiple Sklerose - Schlafstörungen - Modified Fatigue Impact Scale

Keywords

Fatigue - multiple sclerosis - sleep disorders - modified fatigue impact scale
 

  • Literatur

  • 1 Andreasen AK, Spliid PE, Andersen H, Jakobsen J. Fatigue and processing speed are related in multiple sclerosis. Eur J Neurol 2010; 17 (02) 212-8.
    CrossrefPubMedGoogle Scholar
  • 2 Archibald CJ, Fisk JD. Information processing efficiency in patients with multiple sclerosis. J Clin Exp Neuropsychol 2000; 22 (05) 686-701.
    CrossrefPubMedGoogle Scholar
  • 3 Arrondo G, Alegre M, Sepulcre J, Iriarte J, Artieda J, Villoslada P. Abnormalities in brain synchronization are correlated with cognitive impairment in multiple sclerosis. Mult Scler 2009; 15 (04) 509-16.
    CrossrefPubMedGoogle Scholar
  • 4 Attarian HP, Brown KM, Duntley SP, Carter JD, Cross AH. The Relationship of sleep disturbances and fatigue in multiple sclerosis. Arch Neurol 2004; 61: 525-8.
    CrossrefPubMedGoogle Scholar
  • 5 Bakshi R, Shaikh ZA, Miletich RS, Czarnecki D, Dmochowski J, Henschel K, Janardhan ND, Kinkel PR. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler 2000; 06: 181-85.
    CrossrefPubMedGoogle Scholar
  • 6 Benedict RH, Carone DA, Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 2004; 14 (3 Suppl): 36-45.
    CrossrefPubMedGoogle Scholar
  • 7 Bomboi G. et al. Quality and quantity of diffuse and focal white matter disease and cognitive disability of patients with multiple sclerosis. J Neuroimaging. 2010 Jul 6. Epub ahead of print.
    PubMedGoogle Scholar
  • 8 Brodie TG. Fatigue in non-medullated nerves. J Physiol 1902; 28 (03) 181-200.
    CrossrefPubMedGoogle Scholar
  • 9 Brown JN, Howard CA, Kemp DW. Modafinil for the treatment of multiple sclerosis-related fatigue. Ann Pharmacother 2010; 44 (06) 1098-103.
    CrossrefPubMedGoogle Scholar
  • 10 Colosimo C. et al. Fatigue in MS is associated with specific clinical features. Acta Neurol Scand 1995; 92 (05) 353-5.
    PubMedGoogle Scholar
  • 11 DeLuca J, Johnson SK, Beldowicz D, Natelson BH. Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis, and depression. J Neurol Neurosurg Psychiatry 1995; 58 (01) 38-43.
    CrossrefPubMedGoogle Scholar
  • 12 DeLuca J, Johnson SK, Natelson BH. Information processing in chronic fatigue syndrome and multiple sclerosis. Arch Neurol 1993; 50: 301-4.
    CrossrefPubMedGoogle Scholar
  • 13 Demaree HA, DeLuca J, Gaudino EA, Diamond BJ. Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation. J Neurol Neurosurg Psychiatry 1999; 67 (05) 661-3.
    CrossrefPubMedGoogle Scholar
  • 14 Diamond BJ, Johnson SK, Kaufman M, Graves L. Relationships between information processing, depression, fatigue and cognition in multiple sclerosis. Arch Clin Neuropsychol 2008; 23 (02) 189-99.
    CrossrefPubMedGoogle Scholar
  • 15 Drake AS. et al. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASATwith the Symbol Digit Modalities Test Mult Scler. 2010; 16 (02) 228-37.
    PubMedGoogle Scholar
  • 16 Drew MA, Nicola J, Starkey NJ, Robert RBIsler. Examining the link between information processing speed and executive functioning in multiple sclerosis. Archives of Clinical Neuropsychology 2009; 24: 47-58.
    CrossrefPubMedGoogle Scholar
  • 17 Duchesne EA. Des chemins de fer et de leur influence sur la santé des mécaniciens et des chauffeurs. Paris: Bachelier, Imprimeur-Librairie de l’Ecole Polytechnique et du Bureau des Longitudes; 1857: 183-5.
    Google Scholar
  • 18 Ferini-Strambi L. et al. Nocturnal sleep study in multiple sclerosis: correlations with clinical and brain magnetic resonance imaging findings. J Neurol Sci 1994; 125: 194-7.
    CrossrefPubMedGoogle Scholar
  • 19 Filippi M. et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 2002; 15 (03) 559-67.
    CrossrefPubMedGoogle Scholar
  • 20 Flachenecker P. et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 2002; 08 (06) 523-6.
    CrossrefPubMedGoogle Scholar
  • 21 Fleming WE, Pollak CP. Sleep disorders in multiple sclerosis. Semin Neurol 2005; 25: 64-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Fletcher WM. The osmotic properties of muscle, and their modifications in fatigue and rigor. J Physiol 1904; 30 (5–6): 414-38.
    CrossrefPubMedGoogle Scholar
  • 23 Fossati P, Radtchenko A, Boyer P. Neuroplasticity: from MRI to depressive symptoms. Eur Neuropsychopharmacol 2004; 14 (Suppl. 05) 503-10.
    CrossrefPubMedGoogle Scholar
  • 24 Fukuda K. et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 953-9.
    CrossrefPubMedGoogle Scholar
  • 25 Goodman AD, Hyland M. Dalfampridine in multiple sclerosis. Drugs Today (Barc) 2010; 46 (09) 635-9.
    CrossrefPubMedGoogle Scholar
  • 26 Gottschalk M. et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol 2005; 62: 277-80.
    CrossrefPubMedGoogle Scholar
  • 27 Greim B, Benecke R, Zettl UK. Qualitative and quantitative assessment of fatigue in multiple sclerosis. J Neurol 2007; 254 (Suppl. 02) 58-64.
    Google Scholar
  • 28 Grossman P. et al. MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology 2010; 75 (13) 1141-9.
    CrossrefPubMedGoogle Scholar
  • 29 Habukawa M. et al. Effect of CPAP treatment on residual depressive symptoms in patients with major depression and coexisting sleep apnea: Contribution of daytime sleepiness to residual depressive symptoms. Sleep med 2010; 11: 552-7.
    CrossrefPubMedGoogle Scholar
  • 30 Heesen C. et al. Altered cytokine responses to cognitive stress in multiple sclerosis patients with fatigue. Mult Scler 2005; 11: 51-7.
    CrossrefPubMedGoogle Scholar
  • 31 Heesen C. et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?. J Neurol Neurosurg Psychiatry 2006; 77: 34-9.
    CrossrefPubMedGoogle Scholar
  • 32 Heesen C. et al. Correlates of cognitive dysfunction in multiple sclerosis. Brain Behav Immun 2010; 24 (07) 1148-55.
    CrossrefPubMedGoogle Scholar
  • 33 Holmes GP. et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108 (03) 387-9.
    CrossrefPubMedGoogle Scholar
  • 34 Huitinga I. et al. Impaired hypothalamus-pituitaryadrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol 2004; 55 (01) 37-45.
    CrossrefPubMedGoogle Scholar
  • 35 Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992; 15: 376-81.
    CrossrefPubMedGoogle Scholar
  • 36 Jongen PJ. et al. Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study. Health Qual Life Outcomes 2010; 08: 133.
    CrossrefPubMedGoogle Scholar
  • 37 Kaynak H. et al. Fatigue and sleep disturbance in multiple sclerosis. Eur J Neurol 2006; 13: 1333-9.
    CrossrefPubMedGoogle Scholar
  • 38 Koch M. et al. Fatigue, depression and disability accumulation in multiple sclerosis: a cross-sectional study. Eur J Neurol 2009; 16 (03) 348-52.
    CrossrefPubMedGoogle Scholar
  • 39 Krupp LB. et al. Fatigue in multiple sclerosis. Arch Neurol 1988; 45: 435-37.
    CrossrefPubMedGoogle Scholar
  • 40 Krupp LB. et al. The fatigue severity scale. Arch Neurol 1989; 46: 1121-3.
    CrossrefPubMedGoogle Scholar
  • 41 Lee FS. The effects of temperature and humidity on fatigue. Am J Public Health (NY) 1912; 02 (11) 863-70.
    CrossrefPubMedGoogle Scholar
  • 42 Lengenfelder J. et al. Processing speed interacts with working memory efficiency in multiple sclerosis. Archives of Clinical Neuropsychology 2006; 21: 229-38.
    CrossrefPubMedGoogle Scholar
  • 43 Levy AG. A further research into fatigue of the central nervous system when caused by electrical stimulation. J Physiol 1902; 28 (1–2): 1-13.
    CrossrefPubMedGoogle Scholar
  • 44 Levy AG. An attempt to estimate fatigue of the cerebral cortex when caused by electrical excitation. J Physiol 1901; 26 (3–4): 210-28.
    CrossrefPubMedGoogle Scholar
  • 45 Melanson M. et al. Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon beta. Int J Neurosci 2010; 120 (10) 631-40.
    CrossrefPubMedGoogle Scholar
  • 46 Merkelbach S. et al. Fatigue, sleepiness, and physical activity in patients with multiple sclerosis. J Neurol 2011; 258 (01) 74-9.
    CrossrefPubMedGoogle Scholar
  • 47 Metz LM. et al. The effect of immunomodulatory treatment on multiple sclerosis fatigue. J Neurol Neurosurg Psychiatry 2004; 75: 1045-7.
    CrossrefPubMedGoogle Scholar
  • 48 Mills RJ, Young CA. The relationship between fatigue and other clinical features of multiple sclerosis. Mult Scler. 2010 Dec 6. Epub ahead of print.
    PubMedGoogle Scholar
  • 49 Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Paralyzed Veterans of America; Washington, DC: 1998
    Google Scholar
  • 50 No authors listed. Fatigue of sights. Science 1889; 13 (311): 41.
    PubMedGoogle Scholar
  • 51 Oka Y, Kanbayashi T. Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis. J Neurol 2004; 251: 885-6.
    PubMedGoogle Scholar
  • 52 Papu E. et al. CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients. Neurosci Lett 2010; 474 (01) 9-12.
    CrossrefPubMedGoogle Scholar
  • 53 Patrick E, Christodoulou C, Krupp LB. New York State MS Consortium. Longitudinal correlates of fatigue in multiple sclerosis. Mult Scler 2009; 15 (02) 258-61.
    CrossrefPubMedGoogle Scholar
  • 54 Pellicano C. et al. Relationship of cortical atrophy to fatigue in patients with multiple sclerosis. Arch Neurol 2010; 67 (04) 447-53.
    PubMedGoogle Scholar
  • 55 Penner Iris Katarina. Fatigue bei Multipler Sklerose. Bad Honnef: Hippocampus Verlag; 008
    Google Scholar
  • 56 Pucci E. et al. Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev. 2007 24. (1): CD002818.
    PubMedGoogle Scholar
  • 57 Putzki N. et al. Multiple sclerosis associated fatigue during natalizumab treatment. J Neurol Sci 2009; 285 (1–2): 109-13.
    CrossrefPubMedGoogle Scholar
  • 58 Rudick RA, Panzara MA. Natalizumab for the treatment of relapsing multiple sclerosis. Biologics 2008; 02 (02) 189-99.
    Google Scholar
  • 59 Schwartz J, Karatinos G. For individuals with obstructive sleep apnea, institution of CPAP therapy is associated with an amelioration of symptoms of depression which is sustained long term. J Clin Sleep Med 2007; 03: 631-5.
    Google Scholar
  • 60 Sepulcre J. et al. Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways. Mult Scler 2009; 15: 337-44.
    CrossrefPubMedGoogle Scholar
  • 61 Simmons RD, Tribe KL, McDonald EA. Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management. Neurology 2010; 257 (06) 926-36.
    CrossrefPubMedGoogle Scholar
  • 62 Stankoff B. et al. Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study. J Neurol 2005; 64: 1139-43.
    CrossrefPubMedGoogle Scholar
  • 63 Stanton BR, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler 2006; 12: 481-6.
    CrossrefPubMedGoogle Scholar
  • 64 Thorndike E. The mental fatigue due to school work. Science 1899; 09 (234) 862-4.
    CrossrefPubMedGoogle Scholar
  • 65 Weinges-Evers N. et al. Correlation of self-assessed fatigue and alertness in multiple sclerosis. Mult Scler 2010; 16 (09) 1134-40.
    CrossrefPubMedGoogle Scholar
  • 66 Zimmermann P, Fimm B. A test battery for attentional performance. In: Leclercq M, Zimmermann P. (eds.). Applied Neuropsychology of Attention. Theory, Diagnosis and Rehabilitation; 2002: 110-51.
    Google Scholar
  • 67 Zimmermann C, Hohlfeld R. Fatigue in multiple sclerosis. Nervenarzt 1999; 70: 566-74.
    CrossrefPubMedGoogle Scholar
  • 68 Ziemssen T. Multiple sclerosis beyond EDSS: depression and fatigue. J Neurol Sci 2009; 277 (Suppl. 01) 37-41.
    CrossrefPubMedGoogle Scholar
  • 69 Veauthier C. et al. Fatigue in Multiple Sclerosis is closely related to sleep disorder: a polysomnographic cross-sectional study. Mult Scler. 2011 Jan 28. Epub ahead of print.
    PubMedGoogle Scholar